v3.20.4
Share-based Compensation (Tables)
12 Months Ended
Dec. 31, 2020
Schedule of Share-Based Compensation Expense
Share-based compensation expense is included in the following line items in our statement of operations:
202020192018
Cost of revenue45 42 40 
Research and development159 141 133 
Selling, general and administrative180 163 141 
384 346 314 
Summary of Stock Options and Changes
Stock optionsWeighted
 average
exercise
price
 in USD
Weighted
 average
remaining
contractual
 term
Aggregate
 intrinsic
value
Outstanding at January 1, 20201,202,909 52.08 
Granted— — 
Exercised547,174 47.77 
Forfeited11,401 35.53 
Outstanding at December 31, 2020644,334 56.03 3.4666 
Exercisable at December 31, 2020644,334 56.03 3.4666 
Summary of Performance Share Units
Financial performance conditions
SharesWeighted
 average
grant date
 fair value
in USD
Outstanding at January 1, 2020195,098 75.60 
Granted— — 
Vested— — 
Forfeited195,098 75.60 
Outstanding at December 31, 2020— — 

Market performance conditions
SharesWeighted
 average
grant date
 fair value
in USD
Outstanding at January 1, 20201,844,187 125.61 
Granted335,567 164.92 
Vested— — 
Forfeited48,060 125.28 
Outstanding at December 31, 20202,131,694 131.81 
Summary of Restricted Share Units
SharesWeighted
 average
grant date
 fair value
in USD
Outstanding at January 1, 20206,006,591 102.20 
Granted2,616,364 129.05 
Vested2,863,408 102.73 
Forfeited366,861 103.86 
Outstanding at December 31, 20205,392,686 114.83